This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by GREEN, B.
Right arrow Articles by KAVANAGH, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GREEN, B.
Right arrow Articles by KAVANAGH, D.
The British Journal of Psychiatry (2005) 187: 306-313
© 2005 The Royal College of Psychiatrists

REVIEW ARTICLE

Cannabis use and misuse prevalence among people with psychosis

BOB GREEN, MSW

Community Forensic Mental Health Service, Brisbane

ROSS YOUNG

School of Psychology and Counselling, Faculty of Health, Queensland of University of Technology, Carseldine

DAVID KAVANAGH, PhD

Department of Psychiatry, Central Clinical Division, University of Queensland, Brisbane, Australia

Correspondence: Bob Green, Community Forensic Mental Health Service, 42 Albert Street, Brisbane 4001, Australia.Tel: +61 (0)7 7 3221 2511; fax: +61 (0)7 7 3221 6060; e-mail: bob_green{at}health.qld.gov.au

Declaration of interest None.

Background Increasing attention has been given by researchers to cannabis use in individuals with psychosis. As psychoses are relatively low-prevalence disorders, research has been mostly been restricted to small-scale studies of treatment samples. The reported prevalence estimates obtained from these studies vary widely.

Aims To provide prevalence estimates based on larger samples and to examine sources of variability in prevalence estimates across studies.

Method Data from 53 studies of treatment samples and 5 epidemiological studies were analysed.

Results Based on treatment sample data, prevalence estimates were calculated for current use (23.0%), current misuse (11.3%), 12-month use (29.2%), 12-month misuse (18.8%), lifetime use (42.1%) and lifetime misuse (22.5%). Epidemiological studies consistently reported higher cannabis use and misuse prevalence in people with psychosis.

Conclusions The factor most consistently associated with increased odds of cannabis prevalence was specificity of diagnosis. Factors such as consumption patterns and study design merit further consideration.


Related articles in BJP:

Highlights of this issue
KIMBERLIE DEAN
BJP 2005 187: 301-a13. [Full Text]  

PETER TYRER
BJP 2005 187: 394. [Full Text]  



This article has been cited by other articles:


Home page
 Am. J. PsychiatryHome page
M. T. Compton, M. E. Kelley, C. E. Ramsay, M. Pringle, S. M. Goulding, M. L. Esterberg, T. Stewart, and E. F. Walker
Association of Pre-Onset Cannabis, Alcohol, and Tobacco Use With Age at Onset of Prodrome and Age at Onset of Psychosis in First-Episode Patients
Am J Psychiatry, November 1, 2009; 166(11): 1251 - 1257.
[Abstract] [Full Text] [PDF]

Home page
 Schizophr BullHome page
N. D. Volkow
Substance Use Disorders in Schizophrenia--Clinical Implications of Comorbidity
Schizophr Bull, May 1, 2009; 35(3): 469 - 472.
[Abstract] [Full Text] [PDF]

Home page
 Adv. Psychiatr. Treat.Home page
Z. Atakan
Cannabis use by people with severe mental illness - is it important?
Adv. Psychiatr. Treat., November 1, 2008; 14(6): 423 - 431.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
J. H. BARNETT, U. WERNERS, S. M. SECHER, K. E. HILL, R. BRAZIL, K. MASSON, D. E. PERNET, J. B. KIRKBRIDE, G. K. MURRAY, ED. T. BULLMORE, et al.
Substance use in a population-based clinic sample of people with first-episode psychosis
The British Journal of Psychiatry, June 1, 2007; 190(6): 515 - 520.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
C. L. M. CATON, D. S. HASIN, P. E. SHROUT, R. E. DRAKE, B. DOMINGUEZ, M. B. FIRST, S. SAMET, and B. SCHANZER
Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis
The British Journal of Psychiatry, February 1, 2007; 190(2): 105 - 111.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
T. White, A. Anjum, and S. C. Schulz
The Schizophrenia Prodrome
Am J Psychiatry, March 1, 2006; 163(3): 376 - 380.
[Full Text] [PDF]